Pricing Log in Create free account

Korro Bio, Inc. (KRRO) vs Voyager Therapeutics, Inc. (VYGR)

Korro Bio, Inc. and Voyager Therapeutics, Inc. are both Biotechnology companies. Korro Bio, Inc. and Voyager Therapeutics, Inc. are of similar size ($137.1M and $126.9M). Voyager Therapeutics, Inc. grew revenue faster over the last twelve months: −19.1% against −81.9%. Korro Bio, Inc. has the higher net margin (0.00% vs −312.6%) and the higher return on invested capital (0.00% vs −192.6%). Across the 15 metrics below, Korro Bio, Inc. leads on 8 and Voyager Therapeutics, Inc. on 7.

Valuation

Metric KRRO VYGR Biotechnology median
P/E n/m n/m 8.42
P/S 25.66 3.62 10.01
P/B 1.59 0.81 2.21
Price to free cash flow n/m n/m 21.01
EV/EBITDA n/m n/m 0.61
EV/Sales 10.53 0.24 9.41
Earnings yield (107.41%) (87.86%) (31.85%)
Free cash flow yield (41.62%) (97.35%) (24.58%)

Profitability

Metric KRRO VYGR Biotechnology median
Gross margin 100.00% 100.00% 65.16%
Operating margin 0.00% (340.08%) 0.00%
Net margin 0.00% (312.63%) 0.00%
Free cash flow margin 0.00% (352.36%) 0.00%
Return on equity (97.69%) (54.09%) (56.36%)
Return on assets (62.03%) (41.45%) (48.04%)
Return on invested capital 0.00% (192.55%) 0.00%

Growth

Metric KRRO VYGR Biotechnology median
Revenue growth (TTM) (81.87%) (19.07%) 6.02%
EPS growth (last fiscal year) (33.19%) (80.53%) 30.26%
Revenue growth, 5-year CAGR — (25.09%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric KRRO VYGR Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 9.55 7.51 4.72
Net debt to EBITDA 0.64 1.50 0.96

Dividend

Metric KRRO VYGR Biotechnology median
Dividend yield — — 0.08%
Payout ratio — — —

Size

Metric KRRO VYGR Biotechnology median
Market cap 137.09m 126.93m 132.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack